Ercin Kugu – General Manager Turkey & Israel, CSL…
Ercin Kugu, CSL Behring’s general manager for Turkey and Israel, highlights the rare disease company’s footprint in Turkey, explains the different…
Tagged with Rare Diseases
NORD’s Breakthrough Summit: Listening to the Rare Disease…
The National Organization for Rare Disorders (NORD) is set to host its annual Rare Diseases and Orphan Products Breakthrough Summit on October…
Karim Smaira – CEO & Kamel Ghammachi – Chairman,…
Kamel Ghammachi and Karim Smaira are the co-founders of Genpharm, an entrepreneurial success story that now provides market access and marketing…
Abidin Gülmüş – CEO, GEN
Few Turkish companies are experiencing such a transformational moment as GEN. Just in 2021, the Ankara-based organization made its public debut at the…
Patrik Forsell – General Manager, Takeda Denmark
Industry veteran Patrik Forsell oversees Takeda’s operations in Denmark. Here, Forsell talks through how sizeable shifts in the company’s global…
Rodrigo Rodriguez – General Manager, Middle East Cluster,…
Rodrigo Rodriguez, general manager for Takeda’s Middle East cluster, discusses the company’s ambitions in the collective Saudi pharma market,…
Sanofi Genzyme EVP Bill Sibold Reflects on 30 Years of Rare…
Bill Sibold, Executive Vice President and Head of Sanofi Genzyme, highlights the achievements of the company’s Rare Humanitarian Program over the…
Şeyda Atadan Memiş – General Manager, Takeda Turkey
Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey at a pivotal moment when the Shire…
Katharina Gasser – Managing Director, Biogen Switzerland
Biogen Switzerland’s Dr med Katharina Gasser outlines how her affiliate navigated the COVID-19 pandemic from an organisational and communication…
Canada: Federal Consultations on a National Strategy for Rare…
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health Canada's consultation with Canadians on…
Public Insurance Coverage for Rare Disease Patients in China:…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the findings of the first ever analysis into…
Marc-Olivier Geinoz – CEO, Dipharma SA
Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic diseases. Founder & CEO…
